Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Roquefort Thera Share Price
  4. Roquefort Thera Share Regulatory News

Pin to quick picksRoquefort Thera Regulatory News (ROQ)

Roquefort Thera Information
  • There is currently no data for ROQ
1234
Date   Source Headline
26th Mar 20261:00 pmRNS-RInvestor Presentation
26th Mar 202612:08 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSLyramid SPA & MK Cell License Update
2nd Mar 20268:00 amRNSSchedule One - Roquefort Therapeutics PLC
2nd Mar 20267:00 amRNSProposed Acquisition and Fundraise of £8.5 million
25th Feb 20267:00 amRNSTransaction Update & Notice of Intention to Delist
15th Jan 20267:00 amRNS-RResearch Note Published
12th Dec 20257:00 amRNSClinical Trial & License Agreement Update
9th Dec 20257:00 amRNSConversion of CLNs
1st Dec 202510:35 amRNSEx-Entitlement Date - Unlisted RNV Shares
1st Dec 20257:00 amRNSDetermination of Record Date and Entitlement
25th Nov 20257:00 amRNSHolding(s) in Company
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSExecuted License Agreement & Transaction Update
3rd Nov 20257:00 amRNSMK Cell Out-License & Lyramid SPA Update
16th Oct 20257:00 amRNSFundraise & Transaction Update
30th Sep 20257:00 amRNSInterim Results to 30 June 2025
24th Sep 20257:00 amRNS-RInvestor Presentation via Engage Investor
8th Sep 20257:00 amRNSProposed Acquisition of Clinical Stage Company
28th Aug 20257:00 amRNSLyramid SPA 2nd Extension & Carve Out
7th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 20257:00 amRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSLyramid SPA Extension
26th Jun 20251:00 pmRNSResults of AGM
13th Jun 20254:00 pmRNSIssue of Equity
2nd Jun 20257:00 amRNSNotice of Annual General Meeting
23rd May 20257:00 amRNSExtension of Convertible Loan Notes
13th May 20257:00 amRNSCorporate Update
30th Apr 20257:00 amRNSAnnual Report & Financial Statements - 31 Dec 2024
14th Mar 20257:00 amRNSPrivate Placing and Conversion of CLNs
10th Mar 20257:30 amRNSBoard Changes
10th Mar 20257:00 amRNSProposed Sale of Oncogeni Ltd
4th Mar 20257:00 amRNSUpdate on Sale of Lyramid
4th Feb 202510:58 amRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSShare Purchase Agreement Signed - Sale of Lyramid
2nd Jan 20257:00 amRNSProposed Sale of Midkine Portfolio
4th Dec 20244:00 pmRNSDirector Share Distribution
7th Nov 20247:00 amRNSConversion of Convertible Loan Notes
27th Sep 20247:00 amRNSInterim Results to 30 June 2024
23rd Sep 20247:00 amRNSGrant of Japan MK Cell Patent
19th Sep 20247:00 amRNSSTAT-6 siRNA Demonstrates Efficacy in Immunology
2nd Sep 20247:00 amRNSGrant of MK Cell Patent & Licencing Update
27th Jun 202412:46 pmRNSResults of AGM
20th Jun 20247:00 amRNSAppointment of Broker
4th Jun 20247:00 amRNSNotice of Annual General Meeting
23rd May 20247:05 amRNSIssue of Convertible Loan Notes & Board Changes
23rd May 20247:00 amRNSMidkine Antibody Licencing Deal
26th Apr 20247:00 amRNSAnnual Report & Financial Statements - 31 Dec 2023
5th Apr 20247:00 amRNSResponse to Share Price Movement
11th Mar 20247:00 amRNSPositive Results: Midkine mRNA and STAT-6 siRNA
1234

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
KOO
Kooth Plc
LSE
-1.19%
0Q15
Abbott Laborato
LSE
0.00%
ROQ
Roquefort Thera
LSE
0.00%
JAR
Jardine Math.sr
LSE
0.00%
UTL
Util
LSE
-2.45%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-5.26%
PREM
Premier African Minerals
LSE
2.44%
ITM
Itm Power
LSE
-2.57%
MATD
Petro Matad
LSE
-4.00%
PRD
Predator Oil
LSE
-5.11%